logo

For the Inventor, By the Inventor

Hamburg, Germany

Ulrich Schubert

This inventor holds 3 USPTO granted patents. Top assignees: The J. David Gladstone Institutes, University of California. Active years: 2003-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Schubert. Retrieved from https://idiyas.com/inventor/ulrich-schubert-0lvwc4y2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Bethesda, MA (US) (2003)
  • Hamburg, DE (2006)
  • Bethesda, MD (US) (2006)

Company Filing History:

goldMedal2 out of 91 
 
The J. David Gladstone Institutes
 patents
silverMedal1 out of 16,035 
 
University of California
 patents

Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7108988 - Methods of identifying agents for inhibiting lentivirus replication (2006-09-19),
2. 6984486 - Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof (2006-01-10),
3. 6664040 - Compositions and methods for delivery of a molecule into a cell (2003-12-16),

Title: Ulrich Schubert: Innovator in Lentiviral Research

Introduction

Ulrich Schubert is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of lentiviral research, particularly in developing methods to combat lentivirus infections. With a total of three patents to his name, Schubert's work focuses on innovative approaches to inhibit viral replication.

Latest Patents

Schubert's latest patents include groundbreaking methods for identifying agents that inhibit lentivirus replication. One patent provides screening methods for identifying compounds that induce the loss of the lentiviral protein Vpr. Another patent details methods for inhibiting the peptidyl-prolyl cis/trans isomerase (PPIase) activity of a protein that catalyzes the isomerization of cis-peptidylprolyl bonds in Vpr. These compounds are crucial for treating lentiviral infections. Additionally, he has developed synthetic peptides derived from the viral regulatory protein R (Vpr) of HIV-1, which are utilized in biological assays and the development of anti-Vpr antibodies.

Career Highlights

Throughout his career, Ulrich Schubert has worked with esteemed institutions such as the J. David Gladstone Institutes and the University of California. His research has significantly advanced the understanding of lentiviral mechanisms and potential therapeutic targets.

Collaborations

Schubert has collaborated with notable colleagues, including

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…